ENTPD3 and colorectal carcinoma: Molecular markers and enrichment analysis proved the great heterogeneity within the CAF population in CRC and indicated the potential anti-tumor functions of ENTPD3+ CAFs distinct from prototypical tumor-promoting-like CAFs.